Chinook Therapeutics Inc (KDNY) · page 6 of 36
The slide uses data from the RADAR trial to challenge the validity of UACR as a reliable surrogate endpoint for kidney function.
Research note · expose_contradiction · expose_contradiction · dense density
Slide locked Sign in to view
Slide schematic 5/7
callout 0/1 chart 1/1 paragraph 2/2 quote 0/1 source-note 1/1 title 1/1
2 without position callout 1 · quote 1
calloutquote
Components 7
callout line paragraph paragraph quote source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1